Rafael Holdings, Inc.
Trappsol Cyclo
Niemann-Pick Disease Type C
Countdown
177days
FDA decision · ~ Dec 31, 2026 estimated
What's at stake
The FDA's approval decision on Trappsol Cyclo for Niemann-Pick Disease Type C is due ~ Dec 31, 2026. A green light opens the market; a complete response letter (CRL) usually sinks the stock.
Primary source
· SEC 8-K
verified 13h ago
“The company has received acknowledgement from the FDA that our US Expanded Access Program (EAP) can proceed”